Green Cross to Form Cell Therapy Company in China
March 13, 2015 at 09:59 AM EDT
Green Cross, a South Korean biopharma, signed a MOU earlier this month with China's Guizhou provincial government to build a cell therapy manufacturing and distributing center in Guizhou, a southwestern province of China. The company offers a portfolio of approved and investigational cell therapy projects including T cell, NK cell, dendritic cell and stem cells. As a reason for the investment, Green Cross cited the increasing global interest in cell therapy treatments for serious diseases. More details.... Share this with colleagues: // //